Back
Abbott Laboratories (ABT)
Health CareABT · NEW YORK STOCK EXCHANGE, INC. · USD
New to investing? How to read this page →$116.11
−0.50%Weekly undervalued picks
Price · 1 year
Loading live analysis…
Loading analysis…
Intrinsic Investor is for research and education only. Not financial advice.
Key metrics
EPS
$3.73
ROE
12.3%
Gross margin
56.5%
Debt/Equity
0.65x
Revenue growth
7.8%
Abbott Laboratories — company intelligence
Earnings surprises
Q2 2026$1.31 vs $1.29 est+1.4%
Q1 2026$1.15 vs $1.16 est-0.5%
Q4 2025$1.50 vs $1.51 est-0.7%
Q3 2025$1.30 vs $1.31 est-1.1%
Analyst consensus · 33 analysts
24 Buy9 Hold0 Sell
Updated Aug 24, 2026
Insider activity · 90 days
6 buys2 sellsnet -4,318 shares
Morrone Louis H.Buy 12 · Aug 12, 2026
Morrone Louis H.Sell 5,850 · Aug 11, 2026
Gonzalez Patricia PaolaBuy 363 · Jun 30, 2026
Recent SEC filings
8-K — Material event reportAug 20, 2026
4 — Insider transaction reportAug 13, 2026
10-Q — Quarterly reportJul 28, 2026
Latest news
FDA Authorizes Abbott's Libre Duo, First Device To Continuously Monitor Both Glucose And Ketones — Benzinga · 16h ago
10 Health Care Stocks Whale Activity In Today’s Session — Benzinga · 17h ago
The Bottom Fishing Club - Embecta: Excellent Turnaround Prospect In Defensive Medical Products — SeekingAlpha · 1d ago
AI Valuation Narrative
Generates a short bull / bear / catalyst summary from the analytics we already computed. No target prices. Research tool, not investment advice.
Explore more
Peers & similar stocks
Quick links to related tickers for research.
Weekly undervalued picks
Get 3 new value ideas and the fair-value math behind them every week. One email, unsubscribe anytime.
Free. No spam. We only email once per week.
Data is provided "as-is" and may be delayed or incomplete. Intrinsic Investor is for education only and is not investment advice.